Towards long-acting HIV inhibitors

被引：0
|
作者：
Sarah Crunkhorn
机构：
来源：
Nature Reviews Drug Discovery | 2019年 / 18卷 / 11期
关键词：
D O I：
10.1038/d41573-019-00169-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：826 / 826
相关论文
共 50 条
  • [21] Rilpivirine long-acting for the prevention and treatment of HIV infection
    Ferretti, Francesca
    Boffito, Marta
    CURRENT OPINION IN HIV AND AIDS, 2018, 13 (04) : 300 - 307
  • [22] NPs safely prescribing long-acting HIV medications
    不详
    NURSE PRACTITIONER, 2023, 48 (01): : 9 - 9
  • [23] Advances in Long-Acting Agents for the Treatment of HIV Infection
    Aadia I. Rana
    Jose R. Castillo-Mancilla
    Karen T. Tashima
    Raphael L. Landovitz
    Drugs, 2020, 80 : 535 - 545
  • [24] Long-acting injectable for HIV approved for use in the UK
    Kirby, Tony
    LANCET INFECTIOUS DISEASES, 2022, 22 (01): : 26 - 26
  • [25] Long-acting injectable cabotegravir for the prevention of HIV infection
    Clement, Meredith E.
    Kofron, Ryan
    Landovitz, Raphael J.
    CURRENT OPINION IN HIV AND AIDS, 2020, 15 (01) : 19 - 26
  • [26] Long-acting injectable antiretrovirals for HIV treatment and prevention
    Spreen, William R.
    Margolis, David A.
    Pottage, John C., Jr.
    CURRENT OPINION IN HIV AND AIDS, 2013, 8 (06) : 565 - 571
  • [27] Impact of long-acting therapies on the global HIV epidemic
    Chandiwana, Nomathemba C.
    Serenata, Celicia M.
    Owen, Andrew
    Rannard, Steve
    Casas, Carmen Perez
    Scott, Cherise
    Hill, Andrew
    Clayden, Polly
    Flexner, Charles
    AIDS, 2021, 35 : S137 - S143
  • [28] Long-Acting HIV Treatment and Prevention: Closer to the Threshold
    Barnhart, Matthew
    GLOBAL HEALTH-SCIENCE AND PRACTICE, 2017, 5 (02): : 182 - 187
  • [29] Future options for long-acting HIV treatment and prevention
    Arens, Yotam
    Gulick, Roy M.
    CURRENT OPINION IN HIV AND AIDS, 2025, 20 (01) : 39 - 47
  • [30] Long-acting implants to treat and prevent HIV infection
    Weld, Ethel D.
    Flexner, Charles
    CURRENT OPINION IN HIV AND AIDS, 2020, 15 (01) : 33 - 41
12345